Pyogenic liver abscess secondary prevention

Liver abscess Main Page
Pyogenic liver abscess Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating pyogenic liver abscess from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pyogenic liver abscess secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pyogenic liver abscess secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pyogenic liver abscess secondary prevention
CDC on Pyogenic liver abscess secondary prevention
Pyogenic liver abscess secondary prevention in the news
Blogs on Pyogenic liver abscess secondary prevention
Directions to Hospitals Treating Type chapter name here
Risk calculators and risk factors for Pyogenic liver abscess secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Secondary Prevention

• Long term monitoring helps in preventing the complications and recurrence of pyogenic liver abscess.
• Monitor the abscess cavity weekly for adequate drainage using CT or USG.
• Persistent fever more than 2 weeks of therapy is an indication for more aggressive drainage.
• Prolonged antibiotic therapy after discharge of patient is recommended.
• Presence of underlying liver disease is the predisposing factor for the recurrence of pyogenic liver disease.